Related Experiment Video
Updated: Jun 30, 2025

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
The invasive investigation of INOCA in the coronary catheterization lab
Sonya N Burgess1,2, Mamas A Mamas3
1Department of Cardiology, Nepean Hospital, Sydney, Australia.
Insights
Many angina patients lack obstructive coronary disease, often due to undiagnosed microvascular dysfunction or vasospastic angina. Invasive assessment using coronary flow reserve and index of microcirculatory resistance can help manage ischemia with non-obstructive coronary artery disease (INOCA).
Area of Science:
- Cardiology
- Vascular Medicine
- Diagnostic Imaging
Background:
- Over 50% of angina patients present without obstructive coronary artery disease.
- A significant subset of these patients may have undiagnosed microvascular dysfunction or vasospastic angina.
- Ischemia with non-obstructive coronary artery disease (INOCA) is frequently underdiagnosed and undertreated.
Purpose of the Study:
- To review the invasive diagnostic strategies for INOCA.
- To highlight the role of coronary flow reserve (CFR) and index of microcirculatory resistance (IMR) in assessing microvascular function.
- To provide an overview of optimal management pathways for INOCA patients.
Main Methods:
- Invasive assessment in the coronary catheterization laboratory.
- Measurement of coronary flow reserve (CFR) to evaluate blood flow through the coronary arteries.
- Assessment of the index of microcirculatory resistance (IMR) to quantify microvascular dysfunction.
- Acetylcholine provocation testing to diagnose coronary vasospasm.
Main Results:
- INOCA can be caused by microvascular dysfunction and/or vasospastic angina.
- CFR and IMR are key invasive parameters for evaluating microvascular function in INOCA.
- Acetylcholine testing is crucial for identifying coronary vasospasm as a cause of INOCA.
Conclusions:
- Invasive evaluation in the cardiac catheterization lab is essential for diagnosing the causes of INOCA.
- Understanding and diagnosing microvascular dysfunction and vasospastic angina are critical for effective angina management in INOCA patients.
- Optimal management of INOCA relies on accurate invasive assessment of coronary physiology.
Abstract:
Over half of all patients with angina have no angiographically demonstratable obstructive coronary disease, with a significant proportion of these patients having undiagnosed microvascular dysfunction and/or vasospastic angina. In chronic coronary syndrome, ischemia with non-obstructive coronary artery disease (INOCA) often remains undiagnosed, or uninvestigated. INOCAmay occur due to vasospastic angina and microvascular dysfunction and require invasive assessment in the coronary catheterization lab. To evaluate INOCA coronary flow reserve (CFR) and the index of microcirculatory resistance (IMR) are used to assess microvascular dysfunction before acetylcholine provocation testing for coronary spasm. This review provides an overview of the invasive investigation of INOCA in the coronary catheterization lab for patients with angina to be optimally managed.

